ACT1 – Ion Channels and Transporters
α-connexin carboxyl terminal peptide that specifically targets and maintains Cx43 at gap junction sites between cell-cell membrane borders of breast cancer cell.- Thus it augments gap junction activity and impairs proliferation and survival of breast cancer cells with no effect on non-transformed cells.
Technical specification
| Sequence : | H-RQPKIWFPNRRKPWKKRPRPDDLEI-OH | |
| MW : | 3.255.8 g/mol | |
| Purity : | > 95% | |
| Counter-Ion : | TFA Salts | |
| Delivery format : | Lyophilized |
Price
| Product | Size | Price € | Price $ |
| CRB1001536-0.5 mg | 0.5 mg | 193€ | 232$ |
| CRB1001536-1 mg | 1 mg | 282€ | 339$ |
